Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
2.650
0.00 (0.00%)
At close: May 12, 2025, 4:00 PM
2.640
-0.010 (-0.38%)
After-hours: May 12, 2025, 4:35 PM EDT
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $101.53 million as of May 12, 2025. Its market cap has decreased by -36.10% in one year.
Market Cap
101.53M
Enterprise Value
51.25M
1-Year Change
-36.10%
Ranking
Category
Stock Price
$2.65
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has decreased from $197.44M to $101.53M, a decrease of -48.58%. That is a compound annual growth rate of -13.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 101.53M | -33.23% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | 261.96M | 32.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |